Register to get unlimited Level 2

Notice to Shareholders regarding closure

By LSE RNS

Date: Wednesday 14 Jan 2026






RNS Number : 9338O
Goldman Sachs ETF ICAV
14 January 2026
 



 Stock Exchange Announcement


 


For immediate release                                                                              14 January 2026

Goldman Sachs ETF ICAV


Terms not defined in this notice have the same meaning given to them in the ICAV's prospectus (the "Prospectus").


Re: Notice to Shareholders regarding closure of a sub-fund of Goldman Sachs ETF ICAV


Goldman Sachs ETF ICAV (the "ICAV") announces the closure of the Goldman Sachs ActiveBeta Emerging Markets Equity UCITS ETF (ISIN: IE00BJ5CMD00), a sub-fund of the ICAV, (the "Fund") with effect from 02 April 2026 (the "Effective Date").


Procedure for closure of the Fund


 




















On the primary market, if you do not redeem your Shares before the Effective Date, your Shares will be redeemed at the applicable Net Asset Value per Share less any associated Duties and Charges, in accordance with the terms of the Prospectus.


 



For secondary market orders, the last day for trading on each Listing Stock Exchange on which the Shares are listed and traded will be:



23 March 2026



 


For primary market orders, the last day on which applications for the creation and redemption of Shares by Authorised Participants will be:



 


 


24 March 2026


 



Following the compulsorily redemption of all Shares on the Effective Date, the redemption proceeds, calculated as of the Effective Date, will be remitted to Shareholders within 10 Business Days.



 


Full details, including key dates and investor information, are available in the comprehensive notice on the following webpage: Notice to Shareholders regarding closure of sub-fund .


 


ENQUIRIES














Goldman Sachs  



Contact: Andy Moore


Email: andy.moore@gs.com 


Phone: +44 20 7051 4001               






 



 


 


 






This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGZGMMVDGGVZM

..

Email this article to a friend

or share it with one of these popular networks:


Top of Page